Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy
Open Access
- 2 July 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (7) , 1007
Abstract
Allergic diseases are highly prevalent disorders, mainly in industrialized countries where they constitute a high global health problem. Allergy is defined as an immune response “shifted toward a type 2 inflammation” induced by the interaction between the antigen (allergen) and IgE antibodies bound to mast cells and basophils that induce the release of inflammatory mediators that cause the clinical symptoms. Currently, allergen-specific immunotherapy (AIT) is the only treatment able to change the course of these diseases, modifying the type 2 inflammatory response by an allergenic tolerance, where the implication of T regulatory (Treg) cells is considered essential. The pollen of the olive tree is one of the most prevalent causes of respiratory allergic diseases in Mediterranean countries, inducing mainly nasal and conjunctival symptoms, although, in areas with a high antigenic load, olive-tree pollen may cause asthma exacerbation. Classically, olive-pollen allergy treatment has been based on specific immunotherapy using whole-olive pollen extracts. Despite extracts standardization, the effectiveness of this strategy varies widely, therefore there is a need for more effective AIT approaches. One of the most attractive is the use of synthetic peptides representing the B- or T-cell epitopes of the main allergens. This review summarizes experimental evidence of several T-cell epitopes derived from the Ole e 1 sequence to modulate the response to olive pollen in vitro, associated with several possible mechanisms that these peptides could be inducing, showing their usefulness as a safe preventive tool for these complex diseases.Keywords
Funding Information
- Instituto de Salud Carlos III (research grant PI17/01682 and PI20/00903 cofunded by FEDER, CIBERES (ISCIII, 0013), and RETIC (RD09/0076/00101))
- Fundación de la Sociedad Española de Alergología e Inmunología Clínica (Ayudas 2018 REF: 18_A07)
- Fundación Conchita Rábago (L. C-J was supported by Fundación Conchita Rábago.)
- Comunidad de Madrid (M.L-R was supported by PEJD-2019-PRE/BMD-16537 contract, Sistema de Garantía Juvenil).)
This publication has 104 references indexed in Scilit:
- The composition and signaling of the IL-35 receptor are unconventionalNature Immunology, 2012
- Immunotherapy with peptidesAllergy, 2011
- IL-35-mediated induction of a potent regulatory T cell populationNature Immunology, 2010
- Heterogeneity of natural Foxp3 + T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticityProceedings of the National Academy of Sciences, 2009
- In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposureJournal of Experimental Medicine, 2008
- Olive cultivar origin is a major cause of polymorphism for Ole e 1 pollen allergenBMC Plant Biology, 2008
- Linked T Cell Receptor and Cytokine Signaling Govern the Development of the Regulatory T Cell RepertoireImmunity, 2008
- Nonredundant roles for Stat5a/b in directly regulating Foxp3Blood, 2007
- T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory ActivityPLOS Medicine, 2005
- Prediction of chain flexibility in proteinsThe Science of Nature, 1985